Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01841437 · ClinicalTrials.gov registry record
Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry
A clinical trial, sponsored by Glaukos Corporation.
- Completed
- Registry status
- 191
- Enrollment target
NCT01841437: Completed study, sponsored by Glaukos Corporation.
NCT01841437 is a clinical trial that has completed, run by Glaukos Corporation. The registered enrollment target is 191 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01841437 has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- 191 participants
- Enrollment target
Study Summary
The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.
Interventions
- DEVICE iStent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06-21 |
What the finished NCT01841437 record still lists
NCT01841437 is an observational study that tracks outcomes without assigning an intervention. The registered 191 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which iStent is the first listed.
NCT01841437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01841437 about?
NCT01841437 is a clinical study titled "Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry". The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.
What is the current status of trial NCT01841437?
This trial is currently completed. The enrollment target is 191 participants. The study started on 2013-09. Estimated completion is 2016-06-21.
What interventions are being tested in trial NCT01841437?
The interventions under investigation include: iStent (DEVICE).
Who is sponsoring clinical trial NCT01841437?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04621435 · 191 participants · Phase 1
Imaging of Solid Tumors Using FAP-2286
- NCT06810544 · 191 participants · Phase 1
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia